ScholarIQanswers from OpenAlex & ORCID
Michelino De Laurentiis
ResearcherPublications, citations & collaboration network
Michelino De Laurentiis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michelino De Laurentiis have?
ScholarIQindexed works
Michelino De Laurentiis has 613 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michelino De Laurentiis have?
ScholarIQcitation count
Michelino De Laurentiis has 20,227 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michelino De Laurentiis?
ScholarIQh-index
Michelino De Laurentiis has an h-index of 68 in OpenAlex.
What is the i10-index of Michelino De Laurentiis?
ScholarIQi10-index
Michelino De Laurentiis has an i10-index of 207 in OpenAlex.
What is the ORCID of Michelino De Laurentiis?
ScholarIQorcid
The ORCID for Michelino De Laurentiis is on the source record.
What is the OpenAlex record for Michelino De Laurentiis?
ScholarIQopenalex
The OpenAlex for Michelino De Laurentiis is on the source record.
What are the most-cited papers on Michelino De Laurentiis?
ScholarIQmost cited works
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
David Miles, Joseph Gligorov, Fabrice André, David Cameron, Andreas Schneeweiß, Carlos H. Barrios, Binghe Xu, Andrew Wardley, Diego Kaen, Livia Andrade, Semiglazov Vf, Mattea Reinisch, Shilpen Patel, Monika Patre, L. Morales, Sipahee Lal Patel, Manika Kaul, Teresa Barata, Joyce O’Shaughnessy, Q. Zhang, Binghe Xu, Zhimin Shao, Xiangyu Wang, Cuizhi Geng, Xingchen Yan, Zhongsheng Tong, Kunwei Shen, Yongmei Yin, Tao Sun, James Chih‐Hsin Yang, J Feng, Min Yan, Yan Wang, Qiang Liu, S. Zhang, Michelino De Laurentiis, Armando Santoro, Valentina Guarneri, Marco Colleoni, Clara Natoli, Laura Cortesi, Sabino De Placido, Lorenzo Gianni, Francesco Ferraù, Lorenzo Livi, Alberto Zambelli, Lucia Del Mastro, Giuseppe Tonini, Filippo Montemurro, Giulia Bianchi, R. Pedersini, Salvatore A. Del Prete, Giacomo Allegrini, Giuseppe Naso, Patrizia Vici, D. Loirat, Audrey Mailliez, Franck Priou, Olivier Trédan, F. Dalenc, Christophe Perrin, Joseph Gligorov, Morales-Pancorbo David, Nadine Dohollou, Luís Teixeira, Fabien Brocard, Antoine Arnaud, Suzette Delaloge, Jean‐Philippe Spano, Luigi Mansi, Livia Andrade, Fernanda Damian, José Luiz Pedrini, Sandra M. Aleixo, Roberto Hegg, R. Junior, Mattea Reinisch, Marcus Schmidt, C. Wenzel, E.‐M. Grischke, Andreas Schneeweiß, Marianne Just, Nadia Harbeck, Claudia Schumacher, Ubong Peters, Dorothea Fischer, Helmut Forstbauer, Rüdiger Liersch, Ellen Warner, Nathaniel Bouganim, C. T. Doyle, Julie Price Hiller, Ted Vandenberg, Michel Pavic, Andrew Robinson, Gloria Roldan Urgoiti, Nadia Califaretti, Ahmet Alacacıoğlu, M. Gumus, Bülent Yalçın
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
Fabrice André, Yeon Hee Park, Sung‐Bae Kim, Toshimi Takano, Seock‐Ah Im, Giuliano Borges, João Paulo da Silveira Nogueira Lima, Sercan Aksoy, Joaquín Gavilá Gregori, Michelino De Laurentiis, Giampaolo Bianchini, Rebecca Roylance, Yasuo Miyoshi, Anne Armstrong, Rajni Sinha, Manuel Ruíz Borrego, Elgene Lim, Johannes Ettl, Rinat Yerushalmi, Flora Zagouri, François P. Duhoux, Tanja Fehm, Dhiraj Gambhire, Jillian Cathcart, Wu Cai, Changan Chu, Anton Egorov, Ian E. Krop
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment
PierFranco Conte, P.A. Ascierto, Giorgio Patelli, Romano Danesi, Angelo Vanzulli, Fabio Sandomenico, Paolo Tarsia, Anna Maria Cattelan, Alessia Comes, Michelino De Laurentiis, Alfredo Falcone, Daniele Regge, Luca Richeldi, Salvatore Siena